| Serial Number | 79383436 |
| Word Mark | JAQBO |
| Filing Date | Thursday, September 14, 2023 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 10, 2024 |
| Registration Number | 7592609 |
| Registration Date | Tuesday, December 10, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 8, 2024 |
| Goods and Services | Veterinary pharmaceutical preparations for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions, and Zollinger-Ellison syndrome, and combination antibiotic therapy being antibiotics for the treatment of Helicobacter pylori infection; pharmaceutical agents affecting digestive organs; medicines for treating intestinal disorders; proton-pump inhibitor, namely, medicines for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions, and Zollinger-Ellison syndrome, and combination antibiotic therapy being antibiotics for the treatment of Helicobacter pylori infection; medicines for the prevention and treatment of gastrointestinal diseases; medicines for the treatment of gastrointestinal diseases; medicines for human purposes, namely, medicinal preparations for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions, and Zollinger-Ellison syndrome, and combination antibiotic therapy being antibiotics for the treatment of Helicobacter pylori infection; pharmaceutical preparations for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions, and Zollinger-Ellison syndrome, and combination antibiotic therapy being antibiotics for the treatment of Helicobacter pylori infection; ethical medicinal preparations, namely, medicinal preparations for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions, and Zollinger-Ellison syndrome, and combination antibiotic therapy being antibiotics for the treatment of Helicobacter pylori infection |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 20, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | JEIL PHARMACEUTICAL CO., LTD |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | JEIL PHARMACEUTICAL CO., LTD |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | JEIL PHARMACEUTICAL CO., LTD |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Event Date | Event Description |
| Monday, November 20, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 24, 2023 | APPLICATION FILING RECEIPT MAILED |
| Thursday, May 9, 2024 | ASSIGNED TO EXAMINER |
| Thursday, May 9, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, May 10, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, May 10, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, November 16, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, July 30, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 11, 2024 | REFUSAL PROCESSED BY IB |
| Tuesday, July 30, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, September 3, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, September 3, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, September 3, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, September 3, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, July 30, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, September 3, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, September 18, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 8, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 8, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 10, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, December 10, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Monday, March 10, 2025 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, April 15, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Saturday, May 3, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Thursday, May 15, 2025 | FINAL DISPOSITION NOTICE SENT TO IB |
| Thursday, May 15, 2025 | FINAL DISPOSITION PROCESSED |
| Friday, June 6, 2025 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, April 15, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |